The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 17, 2018

Filed:

Jul. 29, 2014
Applicants:

Cornell University, Ithaca, NY (US);

Purdue Research Foundation, West Lafayette, IN (US);

Inventors:

Francis Barany, New York, NY (US);

Maneesh Pingle, New York, NY (US);

Donald Bergstrom, Portland, OR (US);

Sarah Filippa Giardina, New York, NY (US);

Assignees:

Cornell University, Ithaca, NY (US);

Purdue Research Foundation, West Lafayette, IN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/48 (2006.01); A61K 31/69 (2006.01); C07F 5/02 (2006.01); C07D 233/64 (2006.01); C07D 307/92 (2006.01); C07D 309/30 (2006.01); C07D 319/24 (2006.01); C07D 493/22 (2006.01); C07H 7/02 (2006.01); C07H 9/02 (2006.01); C40B 30/04 (2006.01); A61K 47/54 (2017.01);
U.S. Cl.
CPC ...
A61K 47/48061 (2013.01); A61K 47/545 (2017.08); C07D 233/64 (2013.01); C07D 307/92 (2013.01); C07D 309/30 (2013.01); C07D 319/24 (2013.01); C07D 493/22 (2013.01); C07F 5/02 (2013.01); C07H 7/02 (2013.01); C07H 9/02 (2013.01); C40B 30/04 (2013.01); A61K 31/69 (2013.01);
Abstract

The present invention is directed to a monomer useful in preparing therapeutic compounds. The monomer includes a diversity element which potentially binds to a target molecule with a dissociation constant of less than 300 μM and a linker element connected to the diversity element. The linker element has a molecular weight less than 500 daltons, is connected, directly or indirectly through a connector, to said diversity element, and is capable of forming a reversible covalent bond or non-covalent interaction with a binding partner of the linker element. The monomers can be covalently or non-covalently linked together to form a therapeutic multimer or a precursor thereof. Also disclosed is a method of screening for therapeutic multimer precursors which bind to a target molecule associated with a condition and a method of screening for linker elements capable of binding to one another. The present invention additionally relates to a therapeutic multimer, which includes a plurality of covalently or non-covalently linked monomers, therapeutic monomers, and uses of such dimers and monomers.


Find Patent Forward Citations

Loading…